Clinical Trial Update: The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy

View source ↗

Summary

The Symphony Triple A Study evaluating the Symphony gene expression–based tool to guide adjuvant systemic therapy decisions in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Breast Cancer

Snippet

Sponsor: Diakonessenhuis, Utrecht | Conditions: Breastcancer, Invasive Breast Carcinoma by Gene Expression Profile | Status: COMPLETED